GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 90 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,000 | -20.0% | 10,640 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -64.3% | 10,640 | 0.0% | 0.00% | -66.7% |
| Q1 2016 | $14,000 | -12.5% | 10,640 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $16,000 | -5.9% | 10,640 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $17,000 | -5.6% | 10,640 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $18,000 | -18.2% | 10,640 | -31.5% | 0.00% | -25.0% |
| Q1 2015 | $22,000 | +22.2% | 15,530 | +33.5% | 0.00% | +33.3% |
| Q4 2014 | $18,000 | -25.0% | 11,630 | 0.0% | 0.00% | -25.0% |
| Q3 2014 | $24,000 | – | 11,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |